News

Spencer Pharmaceutical said the patents are related to platform technologies for the efficient delivery of nucleic acids using chitosan as well as for an innovative discovery of therapeutic

Under this program, Jasco Pharma and NCCU are expected to combine the biological platform, tools and expertise at NCCU in the laboratory of Antonio Baines with Jasco Pharma’s

The multicentre, randomized, double-masked, sham injection-controlled, 36-month trial involved 377 patients with DME, who were randomised to receive monthly injections of either 0.3mg Lucentis (n=125), 0.5mg Lucentis (n=125)

The study results showed that adding aflibercept to the chemotherapy drug docetaxel did not meet the pre-specified criteria for primary endpoint, which was defined as improvement in overall

The Kinston facility, which manufactures syringe plungers and other components of intravenous (IV) systems, has around 325 workers. The Lionville, Pennsylvania-based firm intends to upgrade the Kinston plant

This Phase I award offers Avaxia a sum of around $145,000 in research and development funds. Avaxia founder and CEO Barbara Fox said they are delighted to have

Vosaroxin, formerly known as voreloxin, is a first-in-class anticancer quinolone derivative, or AQD, a class of compounds that has not been used previously for the treatment of cancer.

The preliminary Phase I results for the EV71 vaccine in adults showed a good safety profile and preliminary immunogenicity profile. Sinovac subsequently initiated the inoculations in the young

The double-blind, randomized, placebo-controlled Phase 2a study of VX-765 enrolled 60 people with treatment-resistant partial onset epilepsy. The primary endpoint of the study was safety and tolerability, and